These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22937414)

  • 1. Memantine as an augmentation therapy for anxiety disorders.
    Schwartz TL; Siddiqui UA; Raza S
    Case Rep Psychiatry; 2012; 2012():749796. PubMed ID: 22937414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug forecast: memantine, prototype of a new approach to treatment of dementia.
    Guay DR
    Consult Pharm; 2003 Jul; 18(7):625-34. PubMed ID: 16563064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acamprosate calcium as augmentation therapy for anxiety disorders.
    Schwartz TL; Siddiqui UA; Raza S; Costello A
    Ann Pharmacother; 2010 Dec; 44(12):1930-2. PubMed ID: 21062908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.
    Parsons CG; Danysz W; Quack G
    Neuropharmacology; 1999 Jun; 38(6):735-67. PubMed ID: 10465680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: A possible role of nNOS and combined effects with donepezil.
    Ota H; Ogawa S; Ouchi Y; Akishita M
    Exp Gerontol; 2015 Dec; 72():109-16. PubMed ID: 26408226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
    de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.
    Parsons CG; Stöffler A; Danysz W
    Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
    Koltunowska D; Gibula-Bruzda E; Kotlinska JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():242-9. PubMed ID: 23623810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA
    Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label study of tiagabine as augmentation therapy for anxiety.
    Schwartz TL; Azhar N; Husain J; Nihalani N; Simionescu M; Coovert D; Jindal S; Tirmazi S
    Ann Clin Psychiatry; 2005; 17(3):167-72. PubMed ID: 16433059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of memantine in the treatment of dementia.
    Rossom R; Adityanjee ; Dysken M
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):303-12. PubMed ID: 15903287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
    Kulkarni J; Thomas N; Hudaib AR; Gavrilidis E; Grigg J; Tan R; Cheng J; Arnold A; Gurvich C
    CNS Drugs; 2018 Feb; 32(2):179-187. PubMed ID: 29549516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine.
    Toggas SM; Masliah E; Mucke L
    Brain Res; 1996 Jan; 706(2):303-7. PubMed ID: 8822372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation.
    Chen HS; Wang YF; Rayudu PV; Edgecomb P; Neill JC; Segal MM; Lipton SA; Jensen FE
    Neuroscience; 1998 Oct; 86(4):1121-32. PubMed ID: 9697119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.